Quin Van

1.2k citations
24 papers · 1.1k indexed · h-index 14

Impact in

Papers in

    • Acute Myeloid Leukemia Research 9
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 4

Quin Van

24 papers receiving 1.0k citations

Peers

Quin Van
Comparison fields: 5 of 78
  • Geriatrics and Gerontology 99
  • Hematology 192
  • Oncology 390
  • Cancer Research 167
  • Genetics 118
Replace Xu Di with:
Xu Di United States
Céline Van Themsche Canada
Rong Bu Saudi Arabia
Zhiqiang Ning China
Filippa Pettersson Canada
Yidan Ren China
Ji Nie China
Min Du United States
Yoo Ri Kim South Korea
Quin Van relative to Xu Di United States Xu Di's profile →
Citations per field
00.5×3.8×
Xu Di · 1×
Citations per year

Countries citing papers authored by Quin Van

Since Specialization
Citations

This map shows the geographic impact of Quin Van's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quin Van with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quin Van more than expected).

Fields of papers citing papers by Quin Van

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quin Van. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quin Van. The network helps show where Quin Van may publish in the future.

Co-authors

The 25 scholars most cited alongside Quin Van, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Quin Van Line = papers co-authored together Quin Van links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003253
2 1998123
3 2007118
4 199676
5 199973
6
Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.
199967
7 200565
8 200352
9 199542
10 200631
11 199830
12
WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).
200526
13 200325
14 200915
15 199713
16 199811
17 19989
18
WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
20029
19 20065
20 20043

About Quin Van

Quin Van is a scholar working on Hematology, Genetics, Oncology, Immunology and Geriatrics and Gerontology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (9 papers), Acute Myeloid Leukemia Research (9 papers), Cell death mechanisms and regulation (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Retinoids in leukemia and cellular processes (4 papers), NF-κB Signaling Pathways (3 papers), Quinazolinone synthesis and applications (2 papers) and Mast cells and histamine (2 papers). The work is most often cited by research in Geriatrics and Gerontology (99 citations), Hematology (192 citations), Oncology (390 citations), Cancer Research (167 citations) and Genetics (118 citations). Quin Van has collaborated with scholars based in United States, Finland and Slovakia. Frequent co-authors include David Harris, Zeev Estrov, Moshe Talpaz, Hagop M. Kantarjian, Stefan Faderl, Bharat B. Aggarwal, Shishir Shishodia, Elihu H. Estey, Alessandra Ferrajoli and Steven M. Kornblau. Their work appears in journals such as Blood, Leukemia Research, International Journal of Cancer, Cancer Research and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026